These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 11929815

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R, Zhang L, Siegfried JM, Luketich JD, Keohavong P.
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cigarette smoking and other risk factors in relation to p53 expression in breast cancer among young women.
    Gammon MD, Hibshoosh H, Terry MB, Bose S, Schoenberg JB, Brinton LA, Bernstein JL, Thompson WD.
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):255-63. PubMed ID: 10090304
    [Abstract] [Full Text] [Related]

  • 6. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.
    Le Calvez F, Mukeria A, Hunt JD, Kelm O, Hung RJ, Tanière P, Brennan P, Boffetta P, Zaridze DG, Hainaut P.
    Cancer Res; 2005 Jun 15; 65(12):5076-83. PubMed ID: 15958551
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Different p53 mutation patterns in colorectal tumors from smokers and nonsmokers.
    Huang CC, Cheng YW, Chen MC, Lin YS, Chou MC, Lee H.
    Environ Mol Mutagen; 2006 Aug 15; 47(7):527-32. PubMed ID: 16721749
    [Abstract] [Full Text] [Related]

  • 9. Cigarette smoking and KRAS oncogene mutations in sporadic colorectal cancer: results from the Netherlands Cohort Study.
    Weijenberg MP, Aardening PW, de Kok TM, de Goeij AF, van den Brandt PA.
    Mutat Res; 2008 Mar 29; 652(1):54-64. PubMed ID: 18296105
    [Abstract] [Full Text] [Related]

  • 10. Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage.
    Spruck CH, Rideout WM, Olumi AF, Ohneseit PF, Yang AS, Tsai YC, Nichols PW, Horn T, Hermann GG, Steven K.
    Cancer Res; 1993 Mar 01; 53(5):1162-6. PubMed ID: 8439962
    [Abstract] [Full Text] [Related]

  • 11. p53 mutations in esophageal tumors from a high incidence area of China in relation to patient diet and smoking history.
    Bennett WP, von Brevern MC, Zhu SM, Bartsch H, Muehlbauer KR, Hollstein MC.
    Cancer Epidemiol Biomarkers Prev; 1997 Nov 01; 6(11):963-6. PubMed ID: 9367071
    [Abstract] [Full Text] [Related]

  • 12. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
    Hussain SP, Amstad P, Raja K, Sawyer M, Hofseth L, Shields PG, Hewer A, Phillips DH, Ryberg D, Haugen A, Harris CC.
    Cancer Res; 2001 Sep 01; 61(17):6350-5. PubMed ID: 11522624
    [Abstract] [Full Text] [Related]

  • 13. High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan.
    Chen FM, Hou MF, Wang JY, Chen TC, Chen DC, Huang SY, Chung YS, Lin SR.
    Cancer Lett; 2004 Apr 15; 207(1):59-67. PubMed ID: 15050734
    [Abstract] [Full Text] [Related]

  • 14. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
    Noma C, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S.
    Cancer Lett; 2004 Jul 16; 210(2):197-203. PubMed ID: 15183535
    [Abstract] [Full Text] [Related]

  • 15. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma.
    Wang X, Christiani DC, Mark EJ, Nelson H, Wiencke JK, Gunn L, Wain JC, Kelsey KT.
    Cancer; 1999 Apr 15; 85(8):1734-9. PubMed ID: 10223567
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. P53 alterations in bladder tumors from arsenic and tobacco exposed patients.
    Moore LE, Smith AH, Eng C, DeVries S, Kalman D, Bhargava V, Chew K, Ferreccio C, Rey OA, Hopenhayn C, Biggs ML, Bates MN, Waldman FM.
    Carcinogenesis; 2003 Nov 15; 24(11):1785-91. PubMed ID: 12919957
    [Abstract] [Full Text] [Related]

  • 18. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
    Eachkoti R, Hussain I, Afroze D, Aejazaziz S, Jan M, Shah ZA, Das BC, Siddiqi MA.
    Cancer Lett; 2007 Apr 18; 248(2):308-20. PubMed ID: 16996204
    [Abstract] [Full Text] [Related]

  • 19. A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking, and occupational exposure to asbestos.
    Kannio A, Ridanpää M, Koskinen H, Partanen T, Anttila S, Collan Y, Hietanen E, Vainio H, Husgafvel-Pursiainen K.
    Cancer Epidemiol Biomarkers Prev; 1996 Jan 18; 5(1):33-9. PubMed ID: 8770464
    [Abstract] [Full Text] [Related]

  • 20. The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers.
    Colilla S, Kantoff PW, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Brown M, Weber BL, Rebbeck TR.
    Carcinogenesis; 2006 Mar 18; 27(3):599-605. PubMed ID: 16244359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.